Position in OGN
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$67
+$38 QoQ
Shares Held
5
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#603
of 626 holders
Holding Since
Jun 2021
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Blume Capital Management, Inc. holds $20,264,751 across 12 Drug Manufacturers - General names. OGN ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
45,083 | $11,449,729 | |
| 2 | PFE |
Pfizer Inc
|
241,130 | $5,806,410 | |
| 3 | SNY |
Sanofi
|
47,681 | $2,034,071 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
3,160 | $399,234 | |
| 5 | AMGN |
Amgen Inc
|
530 | $191,923 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,400 | $179,900 | |
| 7 | LLY |
ELI LILLY & Co
|
60 | $71,965 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,054 | $60,731 |
All Filings in OGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67 | 5 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $29 | 5 | Shares | Sole | 2026-05-01 | |
| 2022-06-30 | $3,138 | 93 | Shares | Sole | 2022-08-11 | |
| 2021-09-30 | $1,311 | 40 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,354 | 210 | Shares | Sole | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||